MMP-9 and uPAR regulated glioma cell migration

References

• Giese A, Westphal M. Glioma invasion in the central nervous system. Neurosurgery 1996; 39:235 - 50, discussion 250-2; http://dx.doi.org/10.1097/00006123-199608000-00001; PMID: 8832660
   PubMed Web of Science ®Google Scholar
• Kachra Z, Beaulieu E, Delbecchi L, Mousseau N, Berthelet F, Moumdjian R, et al. Expression of matrix metalloproteinases and their inhibitors in human brain tumors. Clin Exp Metastasis 1999; 17:555 - 66; http://dx.doi.org/10.1023/A:1006760632766; PMID: 10845554
   PubMed Web of Science ®Google Scholar
• Raithatha SA, Muzik H, Muzik H, Rewcastle NB, Johnston RN, Edwards DR, et al. Localization of gelatinase-A and gelatinase-B mRNA and protein in human gliomas. Neuro Oncol 2000; 2:145 - 50; PMID: 11302334
   PubMed Web of Science ®Google Scholar
• Rooprai HK, Van Meter T, Rucklidge GJ, Hudson L, Everall IP, Pilkington GJ. Comparative analysis of matrix metalloproteinases by immunocytochemistry, immunohistochemistry and zymography in human primary brain tumours. Int J Oncol 1998; 13:1153 - 7; PMID: 9824624
   PubMed Web of Science ®Google Scholar
• Rao JS, Steck PA, Mohanam S, Stetler-Stevenson WG, Liotta LA, Sawaya R. Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors. Cancer Res 1993; 53:Suppl 2208 - 11; PMID: 8485704
   PubMed Web of Science ®Google Scholar
• Veeravalli KK, Chetty C, Ponnala S, Gondi CS, Lakka SS, Fassett D, et al. MMP-9, uPAR and cathepsin B silencing downregulate integrins in human glioma xenograft cells in vitro and in vivo in nude mice. PLoS One 2010; 5:e11583; http://dx.doi.org/10.1371/journal.pone.0011583; PMID: 20657647
   PubMedGoogle Scholar
• Nalla AK, Gorantla B, Gondi CS, Lakka SS, Rao JS. Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells. Cancer Gene Ther 2010; 17:599 - 613; http://dx.doi.org/10.1038/cgt.2010.16; PMID: 20448670
   PubMed Web of Science ®Google Scholar
• Veeravalli KK, Ponnala S, Chetty C, Tsung AJ, Gujrati M, Rao JS. Integrin α9β1-mediated cell migration in glioblastoma via SSAT and Kir4.2 potassium channel pathway. Cell Signal 2012; 24:272 - 81; http://dx.doi.org/10.1016/j.cellsig.2011.09.011; PMID: 21946432
   PubMed Web of Science ®Google Scholar
• Chetty C, Vanamala SK, Gondi CS, Dinh DH, Gujrati M, Rao JS. MMP-9 induces CD44 cleavage and CD44 mediated cell migration in glioblastoma xenograft cells. Cell Signal 2012; 24:549 - 59; http://dx.doi.org/10.1016/j.cellsig.2011.10.008; PMID: 22024282
   PubMed Web of Science ®Google Scholar
• Rao JS. Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 2003; 3:489 - 501; http://dx.doi.org/10.1038/nrc1121; PMID: 12835669
   PubMed Web of Science ®Google Scholar
• Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 2010; 10:9 - 22; http://dx.doi.org/10.1038/nrc2748; PMID: 20029421
   PubMed Web of Science ®Google Scholar
• Goldbrunner RH, Bernstein JJ, Tonn JC. ECM-mediated glioma cell invasion. Microsc Res Tech 1998; 43:250 - 7; http://dx.doi.org/10.1002/(SICI)1097-0029(19981101)43:3<250::AID-JEMT7>3.0.CO;2-C; PMID: 9840803
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Sawaya R, Mohanam S, Rao VH, Bruner JM, Nicolson GL, et al. Expression and localization of urokinase-type plasminogen activator receptor in human gliomas. Cancer Res 1994; 54:5016 - 20; PMID: 8069869
   PubMed Web of Science ®Google Scholar
• Smith HW, Marshall CJ. Regulation of cell signalling by uPAR. Nat Rev Mol Cell Biol 2010; 11:23 - 36; http://dx.doi.org/10.1038/nrm2821; PMID: 20027185
   PubMed Web of Science ®Google Scholar
• Aguirre Ghiso JA. Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo. Oncogene 2002; 21:2513 - 24; http://dx.doi.org/10.1038/sj.onc.1205342; PMID: 11971186
   PubMed Web of Science ®Google Scholar
• Degryse B, Resnati M, Czekay RP, Loskutoff DJ, Blasi F. Domain 2 of the urokinase receptor contains an integrin-interacting epitope with intrinsic signaling activity: generation of a new integrin inhibitor. J Biol Chem 2005; 280:24792 - 803; http://dx.doi.org/10.1074/jbc.M413954200; PMID: 15863511
   PubMed Web of Science ®Google Scholar
• Myöhänen HT, Stephens RW, Hedman K, Tapiovaara H, Rønne E, Høyer-Hansen G, et al. Distribution and lateral mobility of the urokinase-receptor complex at the cell surface. J Histochem Cytochem 1993; 41:1291 - 301; http://dx.doi.org/10.1177/41.9.8394852; PMID: 8394852
   PubMed Web of Science ®Google Scholar
• Wei Y, Eble JA, Wang Z, Kreidberg JA, Chapman HA. Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1. Mol Biol Cell 2001; 12:2975 - 86; PMID: 11598185
   PubMed Web of Science ®Google Scholar
• Bohuslav J, Horejsí V, Hansmann C, Stöckl J, Weidle UH, Majdic O, et al. Urokinase plasminogen activator receptor, beta 2-integrins, and Src-kinases within a single receptor complex of human monocytes. J Exp Med 1995; 181:1381 - 90; http://dx.doi.org/10.1084/jem.181.4.1381; PMID: 7535337
   PubMed Web of Science ®Google Scholar
• Aguirre Ghiso JA, Kovalski K, Ossowski L. Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling. J Cell Biol 1999; 147:89 - 104; http://dx.doi.org/10.1083/jcb.147.1.89; PMID: 10508858
   PubMed Web of Science ®Google Scholar
• Carriero MV, Del Vecchio S, Capozzoli M, Franco P, Fontana L, Zannetti A, et al. Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer. Cancer Res 1999; 59:5307 - 14; PMID: 10537314
   PubMed Web of Science ®Google Scholar
• Tang CH, Hill ML, Brumwell AN, Chapman HA, Wei Y. Signaling through urokinase and urokinase receptor in lung cancer cells requires interactions with beta1 integrins. J Cell Sci 2008; 121:3747 - 56; http://dx.doi.org/10.1242/jcs.029769; PMID: 18940913
   PubMed Web of Science ®Google Scholar
• Ghosh S, Johnson JJ, Sen R, Mukhopadhyay S, Liu Y, Zhang F, et al. Functional relevance of urinary-type plasminogen activator receptor-alpha3beta1 integrin association in proteinase regulatory pathways. J Biol Chem 2006; 281:13021 - 9; http://dx.doi.org/10.1074/jbc.M508526200; PMID: 16510444
   PubMed Web of Science ®Google Scholar
• Wei Y, Tang CH, Kim Y, Robillard L, Zhang F, Kugler MC, et al. Urokinase receptors are required for alpha 5 beta 1 integrin-mediated signaling in tumor cells. J Biol Chem 2007; 282:3929 - 39; http://dx.doi.org/10.1074/jbc.M607989200; PMID: 17145753
   PubMed Web of Science ®Google Scholar
• Nguyen DH, Catling AD, Webb DJ, Sankovic M, Walker LA, Somlyo AV, et al. Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner. J Cell Biol 1999; 146:149 - 64; PMID: 10402467
   PubMed Web of Science ®Google Scholar
• Gingras MC, Roussel E, Bruner JM, Branch CD, Moser RP. Comparison of cell adhesion molecule expression between glioblastoma multiforme and autologous normal brain tissue. J Neuroimmunol 1995; 57:143 - 53; http://dx.doi.org/10.1016/0165-5728(94)00178-Q; PMID: 7535788
   PubMed Web of Science ®Google Scholar
• Mahesparan R, Read TA, Lund-Johansen M, Skaftnesmo KO, Bjerkvig R, Engebraaten O. Expression of extracellular matrix components in a highly infiltrative in vivo glioma model. Acta Neuropathol 2003; 105:49 - 57; PMID: 12471461
   PubMed Web of Science ®Google Scholar
• Plow EF, Haas TA, Zhang L, Loftus J, Smith JW. Ligand binding to integrins. J Biol Chem 2000; 275:21785 - 8; http://dx.doi.org/10.1074/jbc.R000003200; PMID: 10801897
   PubMed Web of Science ®Google Scholar
• Brown MC, Staniszewska I, Lazarovici P, Tuszynski GP, Del Valle L, Marcinkiewicz C. Regulatory effect of nerve growth factor in alpha9beta1 integrin-dependent progression of glioblastoma. Neuro Oncol 2008; 10:968 - 80; http://dx.doi.org/10.1215/15228517-2008-0047; PMID: 19074980
   PubMed Web of Science ®Google Scholar
• Gupta SK, Vlahakis NE. Integrin alpha9beta1: Unique signaling pathways reveal diverse biological roles. Cell Adh Migr 2010; 4:194 - 8; http://dx.doi.org/10.4161/cam.4.2.10900; PMID: 20179422
   PubMed Web of Science ®Google Scholar
• Vlahakis NE, Young BA, Atakilit A, Hawkridge AE, Issaka RB, Boudreau N, et al. Integrin alpha9beta1 directly binds to vascular endothelial growth factor (VEGF)-A and contributes to VEGF-A-induced angiogenesis. J Biol Chem 2007; 282:15187 - 96; http://dx.doi.org/10.1074/jbc.M609323200; PMID: 17363377
   PubMed Web of Science ®Google Scholar
• Liu S, Slepak M, Ginsberg MH. Binding of Paxillin to the alpha 9 Integrin Cytoplasmic Domain Inhibits Cell Spreading. J Biol Chem 2001; 276:37086 - 92; http://dx.doi.org/10.1074/jbc.M105114200; PMID: 11477105
   PubMed Web of Science ®Google Scholar
• Young BA, Taooka Y, Liu S, Askins KJ, Yokosaki Y, Thomas SM, et al. The cytoplasmic domain of the integrin alpha9 subunit requires the adaptor protein paxillin to inhibit cell spreading but promotes cell migration in a paxillin-independent manner. Mol Biol Cell 2001; 12:3214 - 25; PMID: 11598204
   PubMed Web of Science ®Google Scholar
• Gupta SK, Vlahakis NE. Integrin alpha9beta1 mediates enhanced cell migration through nitric oxide synthase activity regulated by Src tyrosine kinase. J Cell Sci 2009; 122:2043 - 54; http://dx.doi.org/10.1242/jcs.041632; PMID: 19470583
   PubMed Web of Science ®Google Scholar
• Ponnala S, Veeravalli KK, Chetty C, Dinh DH, Rao JS. Regulation of DNA repair mechanism in human glioma xenograft cells both in vitro and in vivo in nude mice. PLoS One 2011; 6:e26191; http://dx.doi.org/10.1371/journal.pone.0026191; PMID: 22022560
   PubMedGoogle Scholar
• Rolli M, Fransvea E, Pilch J, Saven A, Felding-Habermann B. Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proc Natl Acad Sci U S A 2003; 100:9482 - 7; http://dx.doi.org/10.1073/pnas.1633689100; PMID: 12874388
   PubMed Web of Science ®Google Scholar
• Adachi Y, Lakka SS, Chandrasekar N, Yanamandra N, Gondi CS, Mohanam S, et al. Down-regulation of integrin alpha(v)beta(3) expression and integrin-mediated signaling in glioma cells by adenovirus-mediated transfer of antisense urokinase-type plasminogen activator receptor (uPAR) and sense p16 genes. J Biol Chem 2001; 276:47171 - 7; http://dx.doi.org/10.1074/jbc.M104334200; PMID: 11572856
   PubMed Web of Science ®Google Scholar
• Nagano O, Saya H. Mechanism and biological significance of CD44 cleavage. Cancer Sci 2004; 95:930 - 5; http://dx.doi.org/10.1111/j.1349-7006.2004.tb03179.x; PMID: 15596040
   PubMed Web of Science ®Google Scholar
• Lakka SS, Gondi CS, Yanamandra N, Dinh DH, Olivero WC, Gujrati M, et al. Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth. Cancer Res 2003; 63:2454 - 61; PMID: 12750266
   PubMed Web of Science ®Google Scholar
• Lakka SS, Gondi CS, Dinh DH, Olivero WC, Gujrati M, Rao VH, et al. Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas. J Biol Chem 2005; 280:21882 - 92; http://dx.doi.org/10.1074/jbc.M408520200; PMID: 15824107
   PubMed Web of Science ®Google Scholar
• Gondi CS, Dinh DH, Gujrati M, Rao JS. Simultaneous downregulation of uPAR and MMP-9 induces overexpression of the FADD-associated protein RIP and activates caspase 9-mediated apoptosis in gliomas. Int J Oncol 2008; 33:783 - 90; PMID: 18813792
   PubMed Web of Science ®Google Scholar
• Chetty C, Lakka SS, Bhoopathi P, Gondi CS, Veeravalli KK, Fassett D, et al. Urokinase plasminogen activator receptor and/or matrix metalloproteinase-9 inhibition induces apoptosis signaling through lipid rafts in glioblastoma xenograft cells. Mol Cancer Ther 2010; 9:2605 - 17; http://dx.doi.org/10.1158/1535-7163.MCT-10-0245; PMID: 20716639
   PubMed Web of Science ®Google Scholar